Hospital Universitario Reina Sofía

Futó vizsgálatok

• Még nem toboroz

  Biomarkers in EV Associated With Marrow Adiposity in Anorexia

  NCT06712485· Maimónides Biomedical Research Institute of Córdoba· Forrás

• Még nem toboroz

  Pembrolizumab Plus Belzutifan With or Without Lenvatinib in Localized Renal Cell Carcinoma

  NCT07593040· 2. fázis· Vall d'Hebron Institute of Oncology· Forrás

• Még nem toboroz

  A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)

  2026-525757-37-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Még nem toboroz

  A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)

  2026-525755-82-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Még nem toboroz

  High-Intensity Interval Versus Aerobic Training for Patient-Reported Outcomes in Women With Heart Failure.

  NCT07925515· Universidad Internacional Isabel I de Castilla· Forrás

• Toboroz

  Evaluation of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)

  2025-523288-39-00· 2. fázis· Mediar Therapeutics Inc.· Forrás

• Még nem toboroz

  A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity

  NCT07861100· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

  NCT07919678· 3. fázis· Pfizer· Forrás

• Toboroz

  A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis

  NCT07412704· 1/2. fázis· Bristol-Myers Squibb· Forrás

• Még nem toboroz

  Phase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma

  2025-524969-24-00· 3. fázis· Revolution Medicines Inc.· Forrás

• Még nem toboroz

  Clinical trial to assess the efficacy and safety of a vaccine for olive pollen allergy

  2026-526390-41-00· 3. fázis· Inmunotek S.L.· Forrás

• Toboroz

  A TWO-STAGE, SINGLE-ARM, PHASE II STUDY OF ZONGERTINIB PLUS FULVESTRANT IN PARTICIPANTS WITH HORMONE RECEPTOR-POSITIVE/HER2- NEGATIVE ADVANCED BREAST CANCER HARBORING HER2 MUTATIONS (AGATHA)

  2026-525328-10-00· 2. fázis· Medica Scientia Innovation Research S.L.· Forrás

• Toboroz

  A biomarker enrichment trial of anti-EGFR agents in patients with advanced colorectal cancer (aCRC) with wild-type RAS and right primary tumour location (right-PTL) - ARIEL-ENGIC 04 EU trial

  2025-521209-42-00· 4. fázis· Fondazione GONO G.I.· Forrás

• Toboroz

  Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

  NCT07711002· 3. fázis· AstraZeneca· Forrás

• Még nem toboroz

  A Phase 2, randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of CRD-4730 in patients with heart failure with reduced ejection fraction (HFREF) (CALIBRATE-HF)

  2025-525033-31-00· 2. fázis· Cardurion Pharmaceuticals Inc.· Forrás

• Még nem toboroz

  A study that compares Depigoid Olea (a medication to treat olive pollen allergies) and placebo in patients who have a runny nose and pink and itchy eyes due to olive pollen allergy.

  2026-525840-13-00· 3. fázis· LETI Pharma S.L.U.· Forrás

• Toboroz

  Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

  NCT07473128· 3. fázis· Pharmacosmos A/S· Forrás

• Toboroz

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  NCT07753993· 3. fázis· AstraZeneca· Forrás

• Még nem toboroz

  A Study to Investigate the Efficacy and Safety of Letrozole SIE Compared With Femara® (Both Combined With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast Cancer

  NCT07340658· 3. fázis· Rovi Pharmaceuticals Laboratories· Forrás

• Toboroz

  A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old

  NCT07722546· 2. fázis· Biogen· Forrás

• Toboroz

  A Study to Evaluate Targeted Therapies for Patients with Rheumatoid Arthritis

  2025-523127-21-00· 1. fázis· AbbVie Deutschland GmbH & Co. KG· Forrás

• Toboroz

  Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease

  NCT07549698· 1/2. fázis· CRISPR Therapeutics AG· Forrás

• Toboroz

  A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

  2025-523670-17-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  A Phase 3 Randomized Study Comparing JNJ-79635322 versus Teclistamab in Participants with Relapsed or Refractory Multiple Myeloma

  2025-523815-12-00· 3. fázis· Janssen Cilag International· Forrás

• Még nem toboroz

  Effect of Vitamin D on MyocardIal Fibrosis in Acute Myocarditis

  2025-523092-33-00· 3. fázis· Spanish Society Of Cardiology· Forrás

• Toboroz

  A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

  NCT07650916· 3. fázis· ViiV Healthcare· Forrás

• Toboroz

  Grass/Olive Immunotherapy for Rhinitis and Asthma (GOES)

  2025-521709-42-00· 3. fázis· LETI Pharma S.L.U.· Forrás

• Toboroz

  A study to evaluate the safety and efficacy of oral decitabine plus ivosidenib in newly diagnosed adult patients with acute myeloid leukemia older than 60 years and/or inelegible for standard induction chemotherapy

  2025-523238-17-00· 2. fázis· Fundacion PETHEMA· Forrás

• Toboroz

  A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease

  2025-524001-33-00· 2. fázis· Immunovant Sciences GmbH· Forrás

• Toboroz

  A Study to Investigate Treatment Patterns and Effectiveness of Tislelizumab in European Patients With Resectable or Advanced Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)

  NCT07652736· BeOne Medicines· Forrás

• Toboroz

  A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer (HARMONi-GI3)

  2025-521587-35-00· 3. fázis· Summit Therapeutics Inc.· Forrás

• Toboroz

  An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis

  NCT07620392· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC

  NCT07018947· 2. fázis· Fundacion Clinic per a la Recerca Biomédica· Forrás

• Toboroz

  A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

  NCT07192952· 3. fázis· Bayer· Forrás

• Toboroz

  A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

  NCT07518186· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Colon Cancer

  NCT06783491· 3. fázis· Maimónides Biomedical Research Institute of Córdoba· Forrás

• Toboroz

  A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

  NCT07525206· 3. fázis· AbbVie· Forrás

• Toboroz

  A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis Suppurativa

  NCT07547813· 2. fázis· Almirall, S.A.· Forrás

• Toboroz

  Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

  NCT07566156· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

  NCT07549412· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Toboroz

  A study to compare Venetoclax Azacitidine and Quizartinib Vs Venetoclax and Azacitidine in newly diagnosed acute myeloid leukemia patient´s ineligible for standard induction chemotherapy

  2025-522979-29-00· 3. fázis· Fundacion PETHEMA· Forrás

• Toboroz

  Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)

  NCT07611747· 4. fázis· Instituto de Investigación Marqués de Valdecilla· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

  NCT07227311· 2. fázis· GlaxoSmithKline· Forrás

• Toboroz

  A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

  NCT07355218· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Toboroz

  Study on Prostate Salvage Using High-dose-rate Brachytherapy

  NCT07860528· Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic· Forrás

• Toboroz

  A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

  NCT07287150· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

  NCT07431177· 2. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  NCT07491445· 3. fázis· Revolution Medicines, Inc.· Forrás

• Még nem toboroz

  Treatment for Ph-negative ALL for Adults up to 65 Years

  NCT07443592· PETHEMA Foundation· Forrás

• Még nem toboroz

  Radiofrequency Ablation Multicenter Observational Study in Renal Oncology Patients

  NCT07465458· Humanitas Hospital, Italy· Forrás

Showing 50 of 315.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Vastagbélrák16 toboroz
• Petefészekrák11 toboroz
• Prosztatarák11 toboroz
• Szívelégtelenség10 toboroz
• Tüdőrák10 toboroz
• Hólyagrák8 toboroz
• Rheumatoid arthritis8 toboroz
• Vesedaganat7 toboroz
• Zsírmáj (MASLD/MASH)7 toboroz
• Crohn-betegség6 toboroz
• Elhízás6 toboroz
• Hasnyálmirigyrák6 toboroz
• Lupus (SLE)6 toboroz
• Méhtestrák6 toboroz
• Áttétes emlőrák5 toboroz
• Colitis ulcerosa5 toboroz
• Dermatomyositis and polymyositis (myositis)5 toboroz
• Gyermekkori daganatok5 toboroz
• Krónikus limfoid leukémia (CLL)5 toboroz
• Máj- és epeúti rák5 toboroz
• Mielóma multiplex5 toboroz
• Asztma4 toboroz
• Gyomor- és nyelőcsőrák4 toboroz
• Immune thrombocytopenia (ITP)4 toboroz
• Koszorúér-betegség4 toboroz
• Szisztémás szklerózis (szkleroderma)4 toboroz
• Akut mieloid leukémia (AML)3 toboroz
• Graves' disease and hyperthyroidism3 toboroz
• Hidradenitis suppurativa3 toboroz
• Tripla negatív emlőrák3 toboroz
• Aortic stenosis2 toboroz
• Cytomegalovirus infection2 toboroz
• Follikuláris limfóma2 toboroz
• Krónikus vesebetegség2 toboroz
• Liver cirrhosis2 toboroz
• Méhnyakrák2 toboroz
• Myasthenia gravis2 toboroz
• Osteoarthritis2 toboroz
• Sclerosis multiplex (SM)2 toboroz
• Spondylitis ankylopoetica (Bechterew-kór)2 toboroz
• Vitiligo2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Amiloidózis1 toboroz
• Arthritis psoriatica1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• HIV-fertőzés1 toboroz
• Köpenysejtes limfóma1 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Krónikus mieloid leukémia (CML)1 toboroz
• Magas vérnyomás1 toboroz
• Melanóma1 toboroz
• Myocarditis1 toboroz
• Peripheral artery disease1 toboroz
• Pikkelysömör1 toboroz
• Pitvarfibrilláció1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Sjögren-szindróma1 toboroz
• Spinal cord injury1 toboroz

Lezárt vizsgálatok

• Lezárult

  ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion

  NCT05225961· 4. fázis· Fundación Pública Andaluza para la gestión de la Investigación en Sevilla· Forrás

• Lezárult

  A clinical trial to learn about the effects of VHB937 in people with Alzheimer's disease

  2024-516966-12-00· 2. fázis· Novartis Pharma AG· Forrás

• Fut, nem toboroz

  A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)

  NCT07234942· 1. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study Evaluating BFB759 in Atopic Dermatitis

  2025-521624-30-00· 2. fázis· Bluefin Biomedicine Inc.· Forrás

• Lezárult

  A study to compare the effect of AVT16 and Entyvio® in subjects with moderate to severe active ulcerative colitis.

  2023-507705-34-00· 3. fázis· Alvotech Swiss AG· Forrás

• Fut, nem toboroz

  Phase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced NSCLC (Substudy NSCLC)

  2024-517818-15-00· 1/2. fázis· Merck Healthcare KGaA· Forrás

• Lezárult

  Real World Evidence of Tivozanib as First-line Treatment for Metastatic Clear Cell Renal Cell Carcinoma

  NCT07354282· Spanish Oncology Genito-Urinary Group· Forrás

• Fut, nem toboroz

  Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)

  NCT06726265· 3. fázis· Immutep S.A.S.· Forrás

• Lezárult

  Evaluation of Adherence With Bisphosphonates and Calcium and Vitamin D Supplements in Women With Postmenopausal Osteoporosis

  NCT07105163· Procare Health Iberia S.L.· Forrás

• Lezárult

  KISIMA-02 vaccine-based immunotherapy for patients with pancreatic cancer

  NCT05846516· 1. fázis· Boehringer Ingelheim International GmbH· Forrás

• Lezárult

  A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia

  2024-511057-22-00· 3. fázis· Janssen Cilag International· Forrás

• Toboroz

  A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

  NCT06717698· 2. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed

  NCT06544733· 2/3. fázis· Gilead Sciences Inc.· Forrás

• Lezárult

  Effect of Copper CU64 PSMA I&T scanning to detect potential disease spread to lymph nodes in men with newly diagnosed Prostate Cancer

  2024-512754-16-01· 3. fázis· Curium US LLC· Forrás

• Toboroz

  A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients

  NCT06578078· 3. fázis· Fundación para la Investigación del Hospital Clínico de Valencia· Forrás

• Lezárult

  A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe hidradenitis suppurativa

  2024-511363-28-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás

• Fut, nem toboroz

  Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)

  NCT06497504· 2. fázis· GlaxoSmithKline· Forrás

• Lezárult

  Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from Olea europaea pollen allergy

  2024-511383-88-00· 2/3. fázis· ROXALL Medizin GmbH· Forrás

• Lezárult

  A study to compare efficacy, safety, and immune response of GME751 and EU-authorized Keytruda in adult participants with untreated metastatic lung cancer

  2023-506882-70-00· 3. fázis· H e x a l AG· Forrás

• Lezárult

  A Retrospective Chart Review Study of Patients With CLAD-BOS Post Lung Transplantation

  NCT06503770· Zambon SpA· Forrás

• Leállították

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata

  NCT06444451· 2. fázis· Sanofi· Forrás

• Toboroz

  A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

  NCT06056297· 3. fázis· X4 Pharmaceuticals· Forrás

• Lezárult

  Impact of Methylxanthine Intake and Blue Light Exposure on Adhesive Shoulder Capsulitis.

  NCT06409871· Universidad de Granada· Forrás

• Lezárult

  A Phase 2b, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Dose Finding study to evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GSK1070806 SC injection in Adult Participants with Moderate to Severe Atopic Dermatitis

  NCT05999799· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis

  2023-504564-42-00· 2. fázis· Anaptysbio Inc.· Forrás

• Lezárult

  Regorafenib-pembrolizumab vs. TACE/TARE in intermediate-stage HCC beyond up-to-7.

  NCT04777851· 3. fázis· Translational Research In Oncology· Forrás

• Lezárult

  Study to Assess the Safety, Tolerability and Efficacy of Lurbinectedin and Dostarlimab treatment in patients with endometrial cancer after disease progression to a previous treatment with Platinum-based Chemotherapy. LiDer trial

  2023-508583-30-00· 1/2. fázis· Vall D Hebron Institute Of Oncology· Forrás

• Lezárult

  A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension

  NCT06168409· 3. fázis· AstraZeneca· Forrás

• Lezárult

  A study to investigate the effect of different doses of AZD0780 on low-density lipoprotein cholesterol (LDL-C) levels compared with placebo and its safety and tolerability in participants 18 to 75 years of age with dyslipidemia

  2023-506197-12-00· 2. fázis· Astrazeneca AB· Forrás

• Lezárult

  Single-dose Study of BMS-986326 at Two Dose Levels in Participants with Atopic Dermatitis

  2022-502997-18-00· 1. fázis· Bristol-Myers Squibb Services Unlimited Company· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

  NCT06104124· 3. fázis· Amgen· Forrás

• Lezárult

  Multicenter Phase 2 study to evaluate the efficacy and safety of Cetuximab in combination with Encorafenib plus Binimetinib as induction treatment in BRAF (V600E) mutated MSS, initially resectable or potentially resectable advanced colorectal cancer: CEBBRA study.

  2022-502413-29-00· 2. fázis· Asociacion Grupo Tratamiento De Tumores Digestivos· Forrás

• Lezárult

  A randomized, multi-centre, double-blind, phase II clinical trial of dose finding of Montelukast in patients with erosive osteoarthritis of the hands. HOME study.

  2023-506137-30-00· 2. fázis· Farmalider S.A.· Forrás

• Fut, nem toboroz

  A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus

  NCT05835986· 1. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors

  NCT05855109· Boehringer Ingelheim· Forrás

• Lezárult

  Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

  NCT06153693· 3. fázis· Mineralys Therapeutics Inc.· Forrás

• Fut, nem toboroz

  A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis

  NCT06136741· 2. fázis· Nektar Therapeutics· Forrás

• Lezárult

  A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD (ROCKET-ASCEND)

  NCT05882877· 3. fázis· Amgen Inc.· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults

  NCT06047444· 3. fázis· Ipsen· Forrás

• Leállították

  A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer

  NCT05983367· 2. fázis· Inspirna, Inc.· Forrás

• Lezárult

  A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus

  NCT06013995· 1. fázis· Bristol-Myers Squibb· Forrás

• Lezárult

  A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

  NCT05923099· 2. fázis· LEO Pharma· Forrás

• Lezárult

  A Study to Evaluate the Impact of Liquid Biopsy in Participants With a Clinical Diagnosis of Advanced Cancer

  NCT05846594· Hoffmann-La Roche· Forrás

• Lezárult

  Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

  NCT05882734· 1/2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

  NCT05958407· 3. fázis· LEO Pharma· Forrás

• Lezárult

  A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

  NCT05931367· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)

  NCT05798520· 2. fázis· Biogen· Forrás

• Lezárult

  ZN-c3 in Adult Participants With Metastatic Colorectal Cancer

  2022-502267-37-00· 1/2. fázis· K-Group Beta Inc.· Forrás

• Fut, nem toboroz

  Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension

  NCT05968430· 3. fázis· Mineralys Therapeutics Inc.· Forrás

• Fut, nem toboroz

  Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)

  NCT05883644· 3. fázis· AstraZeneca· Forrás

Showing 50 of 165.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Crohn-betegség34 munka · 11 vizsgálat
• Colitis ulcerosa32 munka · 12 vizsgálat
• Spondylitis ankylopoetica (Bechterew-kór)16 munka · 4 vizsgálat
• Aortic stenosis14 munka · 4 vizsgálat
• Arthritis psoriatica9 munka · 11 vizsgálat
• Alopecia areata5 munka · 4 vizsgálat